A drug that is right for one person could be harmful to another due to differences in health conditions, other medications, or dosing needs
Somatostatin analogs including octreotide, lanreotide, and pasireotide treat neuroendocrine tumors by binding to somatostatin receptors on tumor cells
Od 2022 roku BPC-157 figuruje na licie zabronionej WADA w kategorii S0 substancje niezatwierdzone
As such, to help ensure that all hospitals calculate the allowed amount data elements consistently and calculate them based on the most recent reimbursements, we proposed to require that hospitals base the median allowed amount, the 10th and 90th percentile allowed amounts, and the count of allowed amounts (discussed in a later section) on EDI 835 ERA transaction data from no longer than 12 months prior to posting the MRF
Ahmed J, Reddy BS, Mlbak L, Leser TD, MacFie J